Upload Image (Max 20MB per Image)
The European Medicines Agency (EMA) has accepted to review the Dynavax Technologies Marketing Authorization Application (MAA) for Heplisav. Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis ...
Tags: EMA, Dynax Heplisav, authorization application